J. E. Davis, Director, CEO, and President, on September 01, 2026, sold 10,000 shares in Quest Diagnostics (DGX) for $2,427,200. Following the Form 4 filing with the SEC, Davis has control over a total of 122,423 common shares of the company, with 122,423 shares held directly.
SEC Filing: